No way! But... [Design Issues]

posted by ElMaestro  – Denmark, 2019-12-06 12:14 (500 d 03:22 ago) – Posting: # 20941
Views: 3,972

Hello, both,

» » At this situation, should this subject's data with one period be included in the BE assessment?
»
» No, you could not.

We do not need a T-R comparison in each subject to do an analysis. We are just stuck in that paradigm. We could in principle fit a model with missing period data. And all data could be used for the calculation of the CI.
I do not know why there is a regulatory tradition for only using completers - I would say there is even a potential scientific and ethical advantage of using all period data.

Pass or fail!
ElMaestro

Complete thread:

Activity
 Admin contact
21,419 posts in 4,475 threads, 1,510 registered users;
online 5 (0 registered, 5 guests [including 3 identified bots]).
Forum time: Monday 15:36 UTC (Europe/Vienna)

There is one certainty in drug development
and statistics that one can depend on:
the data are always late.    Scott Patterson and Byron Jones

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5